Canadian miner Lions Bay Mining has announced it has entered into a non-binding letter of intent to acquire BioVaxys, a private company working on a Covid-19 vaccine. The proposed transaction will be structured as an amalgamation or share exchange agreement, subject to mutual agreement, with BioVaxys becoming a wholly-owned subsidiary of Lions Bay.
Read more here.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
